日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Predictive value of the prognostic nutritional index in advanced non-small cell lung cancer patients treated with immune checkpoint inhibitors: A systematic review and meta-analysis

预后营养指数对接受免疫检查点抑制剂治疗的晚期非小细胞肺癌患者的预测价值：系统评价和荟萃分析

期刊:Heliyon
影响因子:3.6
doi:10.1016/j.heliyon.2023.e17400
Xia, Handai; Zhang, Wengang; Zheng, Qi; Zhang, Yuqing; Mu, Xin; Wei, Chenxi; Wang, Xiuwen; Liu, Yanguo
肺癌
肿瘤
肿瘤免疫
细胞生物学
免疫/内分泌
发表日期：2023
文献求助 收藏

Efficacy of immune checkpoint inhibitors in non-small cell lung cancer with NTRK family mutations

免疫检查点抑制剂治疗NTRK家族突变型非小细胞肺癌的疗效

期刊:BMC Pulmonary Medicine
影响因子:2.8
doi:10.1186/s12890-023-02707-x
Shang, Xiaoling; Zhang, Wengang; Han, Wenfei; Xia, Handai; Liu, Ni; Wang, Xiuwen; Liu, Yanguo
肺癌
肿瘤
肿瘤免疫
细胞生物学
免疫/内分泌
发表日期：2023
文献求助 收藏

Fibroblast growth factor receptor family mutations as a predictive biomarker for immune checkpoint inhibitors and its correlation with tumor immune microenvironment in melanoma

成纤维细胞生长因子受体家族突变作为免疫检查点抑制剂的预测性生物标志物及其与黑色素瘤肿瘤免疫微环境的相关性

期刊:Frontiers in Immunology
影响因子:5.9
doi:10.3389/fimmu.2022.1030969
Zhang, Wengang; Xia, Handai; Yang, Rui; Zhang, Yuqing; Zheng, Qi; Shang, Xiaoling; Liu, Ni; Ma, Xinchun; Wei, Chenxi; Chen, Hang; Mu, Xin; Wang, Xiuwen; Liu, Yanguo
黑色素瘤
成纤维细胞
肿瘤
肿瘤免疫
信号转导
细胞生物学
免疫/内分泌
发表日期：2022
文献求助 收藏

Liver metastases and the efficacy of immune checkpoint inhibitors in advanced lung cancer: A systematic review and meta-analysis

晚期肺癌肝转移及免疫检查点抑制剂疗效：系统评价和荟萃分析

期刊:Frontiers in Oncology
影响因子:3.3
doi:10.3389/fonc.2022.978069
Xia, Handai; Zhang, Wengang; Zhang, Yuqing; Shang, Xiaoling; Liu, Yanguo; Wang, Xiuwen
肺癌
肿瘤
肿瘤免疫
免疫/内分泌
发表日期：2022
文献求助 收藏

CDC25C as a Predictive Biomarker for Immune Checkpoint Inhibitors in Patients With Lung Adenocarcinoma

CDC25C作为肺腺癌患者免疫检查点抑制剂的预测性生物标志物

期刊:Frontiers in Oncology
影响因子:3.3
doi:10.3389/fonc.2022.867788
Zhang, Wengang; Shang, Xiaoling; Yang, Fei; Han, Wenfei; Xia, Handai; Liu, Ni; Liu, Yanguo; Wang, Xiuwen
Checkpoint
肿瘤
肿瘤免疫
免疫/内分泌
发表日期：2022
文献求助 收藏

ANK2 as a novel predictive biomarker for immune checkpoint inhibitors and its correlation with antitumor immunity in lung adenocarcinoma.

ANK2 作为一种新型的免疫检查点抑制剂预测生物标志物及其与肺腺癌抗肿瘤免疫的相关性

期刊:BMC Pulmonary Medicine
影响因子:2.8
doi:10.1186/s12890-022-02279-2
Zhang Wengang, Shang Xiaoling, Liu Ni, Ma Xinchun, Yang Rui, Xia Handai, Zhang Yuqing, Zheng Qi, Wang Xiuwen, Liu Yanguo
肿瘤
肺癌
Checkpoint
肿瘤免疫
发表日期：2022
文献求助 收藏